Global Ioversol Market Size To Worth USD 1386.20 Million By 2033 | CAGR Of 7.14%
Category: HealthcareGlobal Ioversol Market Size To Worth USD 1386.20 Million By 2033
According to a research report published by Spherical Insights & Consulting, the Global Ioversol Market Size is Expected to Grow from USD 1386.20 Million in 2023 to us Million By 2033, at a CAGR of 7.14 % during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 189 pages with 121 Market data tables and figures & charts from the report on the "Global Ioversol Market Size, Share, and COVID-19 Impact Analysis, By Injection Type (Ioversol 68%, Ioversol 34%, Ioversol 74%, Ioversol 51%, and Ioversol 64%), By Packaging (Bottles, Power Injector Syringes, Vials, and Power Injector Syringes), By Application (Angiography, X-Ray, CT Scan, Radiological & Diagnostic Examinations, Computed Tomographic Scans, Urography, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/ioversol-market
The ioversol market is a global industry that produces, distributes, and consumes ioversol, a radiopaque contrast agent containing iodine, used in medical imaging technologies like CT scans, X-rays, and angiography. Ioversol enhances contrast in computed tomographic imaging by improving radiographic efficiency. Its maximum contrast enhancement occurs within 15-120 seconds of injection, with optimal contrast within 5-15 minutes. The market growth is driven by the increasing prevalence of cardiovascular diseases and the demand for diagnostic imaging procedures. Heart disease is the leading cause of death in the United States, and the demand for ioversol injections for brain imaging is also increasing. The growing number of neurological diseases and global healthcare infrastructure are driving the demand for ioversol. However, alternative products may impede the growth of the market.
The ioversol 64% segment held the largest share of 26.10% in 2023 and is predicted to grow at a CAGR during the predicted period.
Based on the injection type, the global ioversol market is categorized as ioversol 68%, ioversol 34%, ioversol 74%, ioversol 51%, and ioversol 64%. Among these, the ioversol 64% segment held the largest share of 26.10% in 2023 and is predicted to grow at a CAGR during the predicted period. The segment's growth is driven by improved organ visibility, increased demand for diagnostic procedures like CT scans and angiography, reduced exposure time, non-ionic properties, and reduced side effects.
The power injector syringes segment accounted for the highest market share of 29.42% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the packaging, the global ioversol market is categorized as bottles, power injector syringes, vials, and power injector syringes. Among these, the power injector syringes segment accounted for the highest market share of 29.42% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. Segmental expansion in syringes due to durability, high-pressure injection, non-slip grip, easy operation, auto filling, reduced errors, cost-effectiveness, and growing adoption of novel syringes.
The radiological & diagnostic examinations segment accounted for the highest market share of 36.79% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the application, the global ioversol market is categorized into angiography, X-ray, CT scan, radiological & diagnostic examinations, computed tomographic scans, urography, and others. Among these, the radiological & diagnostic examinations segment accounted for the highest market share of 36.79% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The segmental expansion is driven by the growing demand for diagnostic imaging procedures, improved accessibility in hospitals, radiological advancements, and the increasing prevalence of cardiovascular and orthopedic diseases in the elderly.
North America is expected to hold the greatest share of the global ioversol market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global ioversol market over the forecast period. The rise in chronic diseases like cardiovascular and neurological disorders has increased the demand for diagnostic imaging procedures, leading to an increase in the demand for Ioversol as a contrast agent. This demand is driven by advancements in medical imaging technologies, improved healthcare expenditure in North America, and the geriatric population, as older people are expected to require these procedures more frequently.
Asia Pacific is predicted to hold the fastest-growing region of the global ioversol market throughout the estimated period. The ioversol market is expanding due to rising cardiovascular, bone, and kidney issues, as well as the geriatric population's preference for orthopedic treatments. This growth is driven by rising pharmaceutical spending, increased awareness, and a growing population base in China and India.
Major key players in the global ioversol market are Ultraject, Guerbet, Jiangsu Hengrui Medicine, China Resources Pharmaceutical Co., Mallinckrodt Pharmaceuticals, Liebel-Flarsheim Company LLC, HB Ocean, Stellence Pharmascience Pvt. Ltd., Novalek Pharmaceuticals Pvt. Ltd., A.S. Joshi and Company, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In December 2020, Guerbet, a global leader in medical imaging, received US Food and Drug Administration approval for the commercial sale of its Optiray (Ioversol Injection) Imaging Bulk Package (IBP) and the LF IBP Transfer Set. The IBP, which can fill sterile single-use syringes with a power injector and cleared contrast media transfer set, is an efficient option for reducing single dose vials without requiring preparation in a laminar flow hood or pharmacy facility.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global ioversol market based on the below-mentioned segments:
Global Ioversol Market, By Injection Type
- Ioversol 68%
- Ioversol 34%
- Ioversol 74%
- Ioversol 51%
- Ioversol 64%
Global Ioversol Market, By Packaging
- Bottles
- Power Injector Syringes
- Vials
- Power Injector Syringes
Global Ioversol Market, By Application
- Angiography
- X-Ray
- CT Scan
- Radiological and Diagnostic Examinations
- Computed Tomographic Scans
- Urography
- Others
Global Ioversol Market, By Region
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?